Veracyte, Inc. (VCYT)
33.85
-0.83
(-2.39%)
USD |
NASDAQ |
Mar 06, 16:00
33.86
+0.01
(+0.03%)
After-Hours: 20:00
Veracyte Cash from Investing (Quarterly) : -5.43M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Thermo Fisher Scientific, Inc. | 891.00M |
| FONAR Corp. | -0.398M |
| Interpace Biosciences, Inc. | -0.117M |
| XWELL, Inc. | 1.715M |
| Hypha Labs, Inc. | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 52.58M |
| Cash from Financing (Quarterly) | -0.149M |
| Free Cash Flow | 126.63M |
| Free Cash Flow Per Share (Quarterly) | 0.5996 |
| Free Cash Flow to Equity (Quarterly) | 49.60M |
| Free Cash Flow to Firm (Quarterly) | 48.80M |
| Free Cash Flow Yield | 4.68% |